data_2crc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2crc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.865 0.364 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 35.4 m-80 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.505 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.919 0.39 . . . . 0.0 111.092 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CD ' HD11 ' A' ' 19' ' ' ILE . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 20' ' ' ASN . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.853 0.358 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.563 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 40.6 m-80 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.889 0.376 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.881 0.372 . . . . 0.0 111.121 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.513 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.844 0.354 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.509 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.905 0.384 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.521 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.458 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.466 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.881 0.372 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.535 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.476 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.535 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.852 0.358 . . . . 0.0 111.155 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.417 ' CD ' HD11 ' A' ' 19' ' ' ILE . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 43.0 m-80 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.845 0.355 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.868 0.366 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 19' ' ' ILE . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.412 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.479 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -110.76 131.11 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.363 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -82.71 115.85 21.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 75.25 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.449 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -125.91 38.45 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.853 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -56.11 -50.34 71.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.38 -157.74 3.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 172.06 13.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.649 2.233 . . . . 0.0 112.381 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -175.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 35.4 m-80 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo -69.76 103.96 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -40.75 -46.9 2.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.06 -49.32 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 35.9 t80 -45.51 161.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.5 pm0 -129.44 131.24 46.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 3.8 p -108.41 137.6 19.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.8 91.53 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 0.0 112.364 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.97 164.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m 62.73 39.11 11.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -107.25 148.01 29.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -132.23 157.07 79.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.11 2.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m 62.06 45.13 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.66 160.92 43.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 165.38 31.13 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 -177.29 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m 57.48 43.97 22.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.535 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -59.58 160.16 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -139.77 114.82 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -128.85 1.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.1 p -69.6 171.19 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 m -113.01 117.89 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.86 -83.49 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 175.93 7.42 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.7 2.267 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.64 179.82 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.76 148.97 66.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -69.15 -43.66 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.43 -45.49 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 89.0 t80 -62.07 162.92 8.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -147.25 151.72 37.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.4 t -97.44 133.25 23.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.602 0.715 . . . . 0.0 111.116 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -177.57 1.92 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.742 2.295 . . . . 0.0 112.381 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.58 157.26 17.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.151 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m 49.93 42.74 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -115.45 -51.44 2.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -49.44 139.71 14.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 158.66 56.16 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.658 2.239 . . . . 0.0 112.361 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.8 p -46.26 -43.25 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.69 67.52 2.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.48 54.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 m -55.37 140.69 38.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.4 p -139.04 175.25 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -75.17 136.43 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -46.11 -53.24 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.86 -155.44 25.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -114.77 86.82 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t -88.81 112.61 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.86 -151.76 5.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -179.04 2.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.373 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -90.99 177.33 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.505 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo -69.72 126.83 13.8 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.96 -43.34 95.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.76 -47.87 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 14.2 t80 -64.15 151.91 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 13.8 pt20 -117.94 144.56 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 41' ' ' PRO . 5.5 p -122.62 137.1 27.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.749 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' N ' HG21 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.74 110.68 2.61 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.661 2.241 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.75 162.05 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t 60.13 39.38 19.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 45' ' ' GLN . 30.3 t80 -64.14 150.59 45.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 44' ' ' TYR . 6.8 mp0 -99.68 156.7 35.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.45 3.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m 65.17 45.5 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.51 137.55 15.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -29.12 24.59 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.715 2.276 . . . . 0.0 112.344 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 t -89.87 42.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.6 p -99.5 -50.9 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.417 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -106.04 129.49 54.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -149.67 166.09 30.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.75 179.81 16.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.436 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -49.44 -44.63 45.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -88.34 153.5 21.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 177.46 20.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 176.35 6.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.99 178.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo -69.77 147.68 63.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' ALA . 4.3 mp0 -68.55 -45.1 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.93 -47.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 13.9 t80 -73.81 138.37 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.47 164.18 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.48 132.11 45.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.89 170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 54.5 42.0 31.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -125.64 83.46 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -153.69 153.07 28.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.578 0.704 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 178.28 4.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.294 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 t -74.85 78.27 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.12 103.55 2.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -50.66 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -115.33 42.84 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m 47.89 42.41 16.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 t -74.07 88.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -83.41 -45.51 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.59 55.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.9 p -66.85 -45.59 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -84.25 102.07 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.3 78.69 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -116.03 -178.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.092 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CD ' HD11 ' A' ' 19' ' ' ILE . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 20' ' ' ASN . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo -69.73 131.89 22.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -64.41 -50.15 68.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.82 -53.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 15.1 t80 -45.74 156.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.579 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 1.3 mp0 -124.48 142.59 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 3.3 p -137.12 136.31 20.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.61 0.719 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 110.28 2.51 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.363 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 44' ' ' TYR . . . -52.23 -57.33 10.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 m -37.72 -29.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 1.7 t80 -60.9 132.08 52.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -122.39 152.48 61.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.595 0.712 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.64 45.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.6 p -60.69 -45.03 95.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.3 142.23 2.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.06 2.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.275 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -91.45 -46.73 7.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -130.65 130.94 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.459 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -163.53 119.65 1.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.6 p -157.72 141.63 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.38 132.94 48.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 p -61.4 117.14 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.03 -45.68 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.92 156.1 7.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -178.92 2.56 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.67 179.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.563 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 40.6 m-80 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 110.25 2.5 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -41.17 -44.66 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.2 -59.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -43.97 148.92 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -119.25 145.44 46.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' CG1' ' HD2' ' A' ' 41' ' ' PRO . 95.2 t -93.25 138.94 22.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.577 0.703 . . . . 0.0 111.163 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD2' ' CG1' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.77 89.88 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.632 2.221 . . . . 0.0 112.398 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -35.67 -43.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -86.48 83.6 7.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 45' ' ' GLN . 12.2 t80 -129.38 40.01 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 44' ' ' TYR . 48.8 tt0 -36.21 98.95 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.613 0.72 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.9 Cg_endo -69.8 -179.33 2.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -81.14 47.61 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.15 -82.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 175.78 7.61 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.685 2.257 . . . . 0.0 112.375 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t 50.51 41.77 25.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -80.49 -56.89 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.493 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -47.06 -44.33 20.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.882 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -40.88 158.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.77 -102.33 1.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.4 p -119.5 156.32 30.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.858 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 m -110.55 -48.26 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.63 84.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 178.85 4.15 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 178.74 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.87 148.55 64.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -72.3 -42.53 65.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.13 -47.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 37.2 t80 -67.47 152.92 44.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 14.8 pt20 -130.59 169.0 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.42 129.95 26.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.686 0.755 . . . . 0.0 111.158 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 177.2 5.81 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 112.32 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -94.73 -51.73 4.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 42' ' ' ALA . 68.9 m -34.9 -50.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 23.3 m-85 -62.15 -48.23 81.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 5.0 pt20 -158.14 150.52 17.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.739 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.658 2.239 . . . . 0.0 112.358 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -64.42 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.33 -103.77 2.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.17 6.49 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.358 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -85.34 86.38 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.839 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.5 p -152.99 144.28 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.48 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -110.28 144.23 39.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -67.52 -57.82 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.0 160.23 23.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.2 p -85.61 136.0 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 t -97.55 112.91 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.61 97.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.498 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -176.64 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -55.68 178.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.513 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo -69.75 126.17 13.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 37' ' ' ALA . 3.3 tp10 -55.02 -52.52 62.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.96 -51.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 71.6 t80 -44.52 160.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 32.0 mt-30 -135.33 129.37 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.76 126.28 28.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.727 . . . . 0.0 111.089 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 116.22 4.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.633 2.222 . . . . 0.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.68 87.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -78.69 49.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -129.4 38.73 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.473 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 35.7 tt0 -86.24 139.68 34.3 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 45' ' ' GLN . 54.1 Cg_endo -69.76 -174.16 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.325 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' GLY . 51.3 p -84.6 36.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . 36.47 75.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -41.31 4.42 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.385 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 t -106.07 148.21 28.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -102.78 104.99 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.479 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -157.42 112.54 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -150.31 126.53 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.89 67.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 m -63.31 118.81 8.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 p -150.4 128.38 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.2 85.34 0.61 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.89 178.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.77 145.29 56.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.0 tp10 -62.67 -51.4 67.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.07 -62.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.068 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 79.1 t80 -54.13 140.31 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -125.73 143.34 51.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.98 135.99 28.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.614 0.721 . . . . 0.0 111.192 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 158.97 55.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.359 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.25 149.4 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 t 50.24 42.06 25.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -81.48 -46.89 13.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.915 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -122.15 114.58 30.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.312 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.7 p -44.3 -42.06 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.15 178.76 0.55 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 105.51 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.685 2.257 . . . . 0.0 112.319 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -90.66 156.0 18.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.4 m -93.04 150.77 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -145.66 170.66 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 143.78 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 69.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.1 m -65.93 -44.38 85.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 p -83.59 140.67 32.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.02 143.92 18.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.54 2.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.29 178.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 44' ' ' TYR . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.05 69.15 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 mm-40 -78.61 -42.46 28.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -37.08 -55.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 37.1 t80 -54.47 160.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 34.9 mt-30 -136.73 143.86 43.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -80.32 133.48 56.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.729 . . . . 0.0 111.101 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 53.5 Cg_endo -69.84 130.05 18.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.29 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 m -82.88 38.82 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.467 ' CB ' ' HG2' ' A' ' 41' ' ' PRO . 24.0 t80 -101.04 -39.98 7.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' SER . 2.9 tp-100 -60.35 132.73 90.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.551 0.691 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 7.11 1.05 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.713 2.276 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' GLN . 2.2 m 74.92 52.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.94 -145.12 11.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 168.38 21.77 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -38.51 -44.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -166.56 141.88 4.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.533 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -47.34 -55.04 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -170.38 164.58 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.69 175.31 18.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.435 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -95.16 161.35 14.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.797 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -107.49 103.74 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.83 -156.29 14.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.07 8.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.67 178.45 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.509 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.572 ' CG2' ' CE1' ' A' ' 44' ' ' TYR . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.82 129.92 18.37 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.69 -45.45 92.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.7 -50.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 70.3 t80 -60.38 159.94 9.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 6.9 pt20 -127.23 141.4 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 7.3 p -127.31 137.93 31.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.651 0.738 . . . . 0.0 111.115 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.84 107.09 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.16 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 p -81.43 44.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.572 ' CE1' ' CG2' ' A' ' 23' ' ' THR . 54.9 t80 -81.17 -59.08 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -124.25 113.19 27.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -179.17 2.74 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 0.0 112.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -39.11 -46.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 158.93 33.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -23.78 30.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -168.5 131.51 1.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 t -114.25 140.48 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.446 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -82.76 42.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -122.63 -39.85 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.9 59.26 0.54 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.3 t -87.86 92.48 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 t -55.15 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.62 86.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 178.3 4.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.72 179.08 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.521 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.466 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo -69.8 120.64 7.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 37' ' ' ALA . 56.8 mt-10 -50.59 -45.61 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -36.5 -58.89 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 7.5 t80 -53.22 128.83 29.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -94.55 137.73 33.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 6.2 p -116.22 137.92 23.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.661 0.744 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 53.3 Cg_endo -69.79 102.88 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.695 2.264 . . . . 0.0 112.339 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.74 -47.22 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -53.7 -42.09 67.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -38.55 143.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.89 155.56 86.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.55 0.691 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.91 3.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t 73.19 28.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 114.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 87.53 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -106.49 101.23 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -90.85 170.48 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.496 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -128.24 139.25 52.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.833 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -51.92 147.59 6.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.44 -70.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t 68.61 43.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.889 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -90.36 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.96 138.6 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.532 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 177.52 5.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.398 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -123.14 176.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 131.67 21.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -54.91 -48.85 72.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.49 -62.67 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 48.4 t80 -52.85 131.56 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.96 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -105.51 143.5 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.61 126.03 44.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.628 0.728 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.67 173.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m 61.82 34.82 16.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -115.08 -54.14 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -39.36 151.46 0.21 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.5 2.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 54.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.71 145.06 10.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 96.75 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -81.27 -47.23 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -108.37 -56.13 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.505 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -87.16 99.87 12.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -116.1 43.17 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.24 -82.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.9 p -158.57 130.97 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -85.51 -56.33 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.09 89.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.439 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -176.85 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.3 177.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.523 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo -69.68 118.91 5.97 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.4 mm-40 -45.69 -44.06 13.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.95 -62.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 1.7 t80 -56.1 144.03 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 8.2 mm100 -113.05 157.65 21.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.87 125.76 51.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.64 0.733 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 98.66 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.69 2.26 . . . . 0.0 112.353 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.77 166.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.072 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m 58.12 45.52 17.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 34.3 t80 -126.36 100.79 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -148.26 148.85 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -163.63 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.673 2.249 . . . . 0.0 112.409 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -64.97 -25.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.58 142.59 15.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' SER . 53.6 Cg_endo -69.77 2.56 3.43 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 0.0 112.37 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' PRO . 8.4 t -34.75 111.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -81.76 -50.56 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.864 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.452 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -158.18 150.14 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.834 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.9 p -162.99 121.16 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 122.32 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 t -96.36 -61.45 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.2 m -124.1 100.49 6.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.68 99.12 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -105.04 178.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.412 HG22 ' CG ' ' A' ' 45' ' ' GLN . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.73 138.73 38.59 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.81 -36.55 82.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -42.04 -46.76 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 56.4 t80 -65.79 158.77 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.9 mm100 -143.37 140.12 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.0 t -73.05 130.27 85.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 160.06 51.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.02 179.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 42' ' ' ALA . 97.5 p -33.37 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 44' ' ' TYR . 1.3 t80 -125.51 -42.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' HG22 ' A' ' 23' ' ' THR . 16.5 tm0? -55.64 127.72 67.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.593 0.711 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -179.97 3.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.9 p -83.61 -33.8 25.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.97 145.48 10.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -2.15 9.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' SER . 32.9 t -55.8 130.63 44.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' SER . 4.7 t 35.07 49.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.484 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.1 p -60.56 132.58 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -141.44 122.54 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.1 4.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 m -68.31 115.98 8.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.38 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 t -61.1 -60.57 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 72.87 1.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 172.34 12.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.02 177.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.535 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.476 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 44' ' ' TYR . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.535 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 114.43 3.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.9 mt-10 -42.81 -45.62 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.57 -62.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -48.85 143.59 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -128.28 137.13 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.58 128.98 84.7 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.617 0.722 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 118.98 6.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.378 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.69 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -81.42 86.26 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 22' ' ' PRO . 55.5 t80 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -75.03 133.63 75.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.615 0.721 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 1.89 4.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.279 . . . . 0.0 112.326 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m 62.82 41.39 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -45.97 153.14 0.88 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -6.01 17.55 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.9 t 64.23 42.46 5.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -133.63 141.36 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.6 p -112.98 111.31 21.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 m -144.37 134.99 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.59 -139.92 4.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 p -56.49 132.37 51.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 t -51.68 -45.47 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.48 -110.4 4.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.325 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -146.59 178.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.519 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' CD ' HD11 ' A' ' 19' ' ' ILE . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 43.0 m-80 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo -69.78 117.59 5.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -46.17 -45.19 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -39.76 -47.9 2.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 81.4 t80 -62.59 152.73 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.17 141.69 48.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.49 127.01 58.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.718 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 108.34 2.06 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.91 -53.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m -59.18 93.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 2.7 t80 -169.53 131.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -134.14 154.18 79.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.5 Cg_endo -69.8 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.0 t -38.01 -47.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.41 -157.9 44.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 137.32 35.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.756 2.304 . . . . 0.0 112.314 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -71.27 -63.09 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 52' ' ' GLY . 1.2 t -56.74 -56.5 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -90.5 42.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -165.87 137.49 3.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.32 49.26 0.86 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 m -92.83 164.99 13.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.397 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m 58.01 44.23 19.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -46.59 142.81 5.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 174.22 9.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 0.0 112.333 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.7 133.4 25.57 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' ALA . 7.9 tt0 -53.87 -50.39 66.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.73 -63.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 11' ' ' TRP . 56.0 t80 -58.71 116.18 3.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -105.35 142.16 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.36 126.05 87.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 133.32 25.42 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 173.72 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.06 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.6 p 46.16 41.42 8.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 45' ' ' GLN . 25.3 t80 -125.13 41.28 3.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' TYR . 13.7 tt0 -36.96 120.3 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 174.52 9.42 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -55.45 -43.32 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.94 81.31 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -178.85 2.53 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.706 2.27 . . . . 0.0 112.378 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 t -91.56 149.5 21.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -104.28 150.6 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.515 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -47.9 -53.96 14.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.841 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m -83.9 -57.86 3.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.42 -117.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 t -128.69 155.02 45.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.383 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.8 t -109.11 150.73 27.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.88 167.36 35.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -179.33 2.83 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.676 2.251 . . . . 0.0 112.351 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.67 178.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 19' ' ' ILE . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.412 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo -69.82 132.45 23.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -57.69 -41.92 82.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 59.1 t80 -41.59 155.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.29 140.8 51.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.91 123.95 15.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 136.55 33.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.23 -66.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -84.78 131.78 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 50.8 t80 -144.38 128.7 17.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -125.03 115.16 26.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.76 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.733 2.288 . . . . 0.0 112.322 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 m 66.73 45.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -162.96 5.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.61 5.43 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.737 2.291 . . . . 0.0 112.309 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -55.89 -45.69 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -116.21 91.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.48 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.2 p 44.38 42.34 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.854 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -73.22 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.2 66.91 1.73 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -39.19 -45.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.6 t -99.78 95.91 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -43.86 159.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -179.83 3.22 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.55 -176.76 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.479 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.78 137.8 36.27 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.91 -43.8 98.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.63 -49.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -62.07 149.8 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -124.68 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.8 t -101.51 130.86 23.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 162.03 43.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.369 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.96 -178.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 42' ' ' ALA . 37.5 m -33.27 98.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.74 123.17 43.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.52 118.74 74.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.6 Cg_endo -69.75 -173.33 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.662 2.241 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' PRO . 20.5 p -34.95 -53.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.63 89.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.55 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.71 2.274 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -113.19 -52.32 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.6 t -87.29 83.21 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.461 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.865 0.364 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 10.2 m120 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.515 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.55 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 12' ' ' GLN . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.919 0.39 . . . . 0.0 111.092 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 28' ' ' GLU . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.853 0.358 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.562 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 11.8 m120 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.562 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.889 0.376 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.573 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' OE1' HD11 ' A' ' 19' ' ' ILE . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.477 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.881 0.372 . . . . 0.0 111.121 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.518 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.442 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.491 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.844 0.354 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.905 0.384 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.881 0.372 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.612 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.494 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD11 ' OE1' ' A' ' 12' ' ' GLN . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.852 0.358 . . . . 0.0 111.155 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 12.8 m120 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.845 0.355 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.52 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.52 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.868 0.366 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.512 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.527 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -110.76 131.11 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.363 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -82.71 115.85 21.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 75.25 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.449 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -125.91 38.45 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.853 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -56.11 -50.34 71.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.38 -157.74 3.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 172.06 13.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.649 2.233 . . . . 0.0 112.381 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -175.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 10.2 m120 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo -69.76 103.96 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -40.75 -46.9 2.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.06 -49.32 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 35.9 t80 -45.51 161.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.5 pm0 -129.44 131.24 46.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG23 ' HD2' ' A' ' 41' ' ' PRO . 3.8 p -108.41 137.6 19.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.8 91.53 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 0.0 112.364 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.97 164.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m 62.73 39.11 11.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 34.0 t80 -107.25 148.01 29.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -132.23 157.07 79.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.11 2.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m 62.06 45.13 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.66 160.92 43.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 165.38 31.13 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 -177.29 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m 57.48 43.97 22.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.535 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -59.58 160.16 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -139.77 114.82 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -128.85 1.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.1 p -69.6 171.19 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 m -113.01 117.89 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.86 -83.49 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 175.93 7.42 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.7 2.267 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.612 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -125.64 179.82 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.76 148.97 66.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -69.15 -43.66 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.43 -45.49 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 89.0 t80 -62.07 162.92 8.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -147.25 151.72 37.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' HD2' ' A' ' 41' ' ' PRO . 94.4 t -97.44 133.25 23.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.602 0.715 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.72 -177.57 1.92 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.742 2.295 . . . . 0.0 112.381 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.58 157.26 17.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.151 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m 49.93 42.74 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' OH ' HG11 ' A' ' 9' ' ' VAL . 1.4 t80 -115.45 -51.44 2.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -49.44 139.71 14.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 158.66 56.16 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.658 2.239 . . . . 0.0 112.361 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.8 p -46.26 -43.25 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.69 67.52 2.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.48 54.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 m -55.37 140.69 38.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.4 p -139.04 175.25 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -75.17 136.43 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -46.11 -53.24 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.86 -155.44 25.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -114.77 86.82 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t -88.81 112.61 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.86 -151.76 5.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -179.04 2.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.373 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -90.99 177.33 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo -69.72 126.83 13.8 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.96 -43.34 95.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.76 -47.87 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 14.2 t80 -64.15 151.91 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 13.8 pt20 -117.94 144.56 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG23 ' HD2' ' A' ' 41' ' ' PRO . 5.5 p -122.62 137.1 27.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.749 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.74 110.68 2.61 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.661 2.241 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.75 162.05 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t 60.13 39.38 19.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 45' ' ' GLN . 30.3 t80 -64.14 150.59 45.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 44' ' ' TYR . 6.8 mp0 -99.68 156.7 35.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.45 3.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m 65.17 45.5 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.51 137.55 15.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -29.12 24.59 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.715 2.276 . . . . 0.0 112.344 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 t -89.87 42.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.6 p -99.5 -50.9 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.417 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -106.04 129.49 54.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -149.67 166.09 30.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.75 179.81 16.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.436 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -49.44 -44.63 45.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -88.34 153.5 21.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 177.46 20.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 176.35 6.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.99 178.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.55 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 12' ' ' GLN . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo -69.77 147.68 63.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' ALA . 4.3 mp0 -68.55 -45.1 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.93 -47.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 13.9 t80 -73.81 138.37 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.47 164.18 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.3 t -85.48 132.11 45.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.8 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.89 170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 54.5 42.0 31.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -125.64 83.46 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -153.69 153.07 28.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.578 0.704 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 178.28 4.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.294 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 2.5 t -74.85 78.27 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HD2' ' A' ' 49' ' ' PRO . . . -97.12 103.55 2.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD2' ' HA2' ' A' ' 48' ' ' GLY . 54.3 Cg_endo -69.76 -50.66 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -115.33 42.84 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m 47.89 42.41 16.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 t -74.07 88.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -83.41 -45.51 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.59 55.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.9 p -66.85 -45.59 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -84.25 102.07 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.3 78.69 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -116.03 -178.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.092 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 28' ' ' GLU . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo -69.73 131.89 22.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -64.41 -50.15 68.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 39' ' ' GLN . . . -38.82 -53.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 15.1 t80 -45.74 156.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.579 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 10.1 mp0 -124.48 142.59 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 41' ' ' PRO . 3.3 p -137.12 136.31 20.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.61 0.719 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.9 Cg_endo -69.73 110.28 2.51 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 44' ' ' TYR . . . -52.23 -57.33 10.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 m -37.72 -29.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 1.7 t80 -60.9 132.08 52.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -122.39 152.48 61.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.595 0.712 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.64 45.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.6 p -60.69 -45.03 95.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.3 142.23 2.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.06 2.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.275 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -91.45 -46.73 7.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -130.65 130.94 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.459 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -163.53 119.65 1.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.6 p -157.72 141.63 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.38 132.94 48.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 p -61.4 117.14 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.03 -45.68 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.92 156.1 7.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -178.92 2.56 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.67 179.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.562 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 11.8 m120 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.562 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 110.25 2.5 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -41.17 -44.66 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.2 -59.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -43.97 148.92 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -119.25 145.44 46.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 41' ' ' PRO . 95.2 t -93.25 138.94 22.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.577 0.703 . . . . 0.0 111.163 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.77 89.88 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.632 2.221 . . . . 0.0 112.398 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -35.67 -43.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -86.48 83.6 7.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 45' ' ' GLN . 12.2 t80 -129.38 40.01 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 48.8 tt0 -36.21 98.95 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.613 0.72 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.9 Cg_endo -69.8 -179.33 2.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -81.14 47.61 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.15 -82.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 175.78 7.61 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.685 2.257 . . . . 0.0 112.375 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t 50.51 41.77 25.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -80.49 -56.89 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.493 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -47.06 -44.33 20.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.882 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -40.88 158.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.77 -102.33 1.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.4 p -119.5 156.32 30.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.858 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 m -110.55 -48.26 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.63 84.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 178.85 4.15 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 178.74 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.573 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' OE1' HD11 ' A' ' 19' ' ' ILE . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.477 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.87 148.55 64.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -72.3 -42.53 65.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.13 -47.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 37.2 t80 -67.47 152.92 44.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 14.8 pt20 -130.59 169.0 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.42 129.95 26.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.686 0.755 . . . . 0.0 111.158 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 177.2 5.81 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 112.32 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -94.73 -51.73 4.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 42' ' ' ALA . 68.9 m -34.9 -50.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 23.3 m-85 -62.15 -48.23 81.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 5.0 pt20 -158.14 150.52 17.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.739 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.658 2.239 . . . . 0.0 112.358 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -64.42 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.33 -103.77 2.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.17 6.49 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.358 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -85.34 86.38 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.839 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.5 p -152.99 144.28 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.48 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -110.28 144.23 39.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -67.52 -57.82 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.0 160.23 23.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.2 p -85.61 136.0 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 t -97.55 112.91 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.61 97.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.498 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -176.64 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -55.68 178.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo -69.75 126.17 13.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 37' ' ' ALA . 3.3 tp10 -55.02 -52.52 62.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.96 -51.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 71.6 t80 -44.52 160.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 32.0 mt-30 -135.33 129.37 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.76 126.28 28.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.727 . . . . 0.0 111.089 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 116.22 4.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.633 2.222 . . . . 0.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.68 87.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -78.69 49.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 9' ' ' VAL . 56.8 t80 -129.4 38.73 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 35.7 tt0 -86.24 139.68 34.3 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 45' ' ' GLN . 54.1 Cg_endo -69.76 -174.16 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.325 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' GLY . 51.3 p -84.6 36.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . 36.47 75.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -41.31 4.42 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.385 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 t -106.07 148.21 28.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -102.78 104.99 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.479 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -157.42 112.54 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -150.31 126.53 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.89 67.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 m -63.31 118.81 8.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 p -150.4 128.38 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.2 85.34 0.61 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -112.89 178.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.518 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.442 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.491 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.77 145.29 56.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.0 tp10 -62.67 -51.4 67.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.07 -62.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.068 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 79.1 t80 -54.13 140.31 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -125.73 143.34 51.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 41' ' ' PRO . 90.0 t -90.98 135.99 28.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.614 0.721 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.76 158.97 55.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.25 149.4 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 t 50.24 42.06 25.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' OH ' HG11 ' A' ' 9' ' ' VAL . 40.9 t80 -81.48 -46.89 13.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 5.9 tt0 -122.15 114.58 30.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.5 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.312 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.7 p -44.3 -42.06 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.15 178.76 0.55 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 105.51 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.685 2.257 . . . . 0.0 112.319 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -90.66 156.0 18.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.4 m -93.04 150.77 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -145.66 170.66 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 143.78 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 69.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.1 m -65.93 -44.38 85.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 p -83.59 140.67 32.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.02 143.92 18.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.54 2.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.29 178.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.05 69.15 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 mm-40 -78.61 -42.46 28.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -37.08 -55.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 37.1 t80 -54.47 160.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 34.9 mt-30 -136.73 143.86 43.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG13 ' HD2' ' A' ' 41' ' ' PRO . 67.1 t -80.32 133.48 56.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.729 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 53.5 Cg_endo -69.84 130.05 18.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.29 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 m -82.88 38.82 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' CB ' ' HG2' ' A' ' 41' ' ' PRO . 24.0 t80 -101.04 -39.98 7.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -60.35 132.73 90.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.551 0.691 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 7.11 1.05 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.713 2.276 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 m 74.92 52.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.94 -145.12 11.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 168.38 21.77 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -38.51 -44.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -166.56 141.88 4.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.533 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -47.34 -55.04 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -170.38 164.58 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.69 175.31 18.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.435 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -95.16 161.35 14.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.797 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -107.49 103.74 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.83 -156.29 14.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.07 8.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.67 178.45 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' HG21 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.572 ' CG2' ' CE1' ' A' ' 44' ' ' TYR . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.82 129.92 18.37 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.69 -45.45 92.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.7 -50.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 70.3 t80 -60.38 159.94 9.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 6.9 pt20 -127.23 141.4 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HD2' ' A' ' 41' ' ' PRO . 7.3 p -127.31 137.93 31.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.651 0.738 . . . . 0.0 111.115 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.619 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.84 107.09 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.16 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 p -81.43 44.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.572 ' CE1' ' CG2' ' A' ' 23' ' ' THR . 54.9 t80 -81.17 -59.08 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -124.25 113.19 27.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -179.17 2.74 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 0.0 112.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -39.11 -46.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 158.93 33.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -23.78 30.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -168.5 131.51 1.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 t -114.25 140.48 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.446 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -82.76 42.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -122.63 -39.85 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.9 59.26 0.54 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.3 t -87.86 92.48 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 t -55.15 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.62 86.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 178.3 4.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.72 179.08 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo -69.8 120.64 7.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 37' ' ' ALA . 56.8 mt-10 -50.59 -45.61 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -36.5 -58.89 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 7.5 t80 -53.22 128.83 29.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -94.55 137.73 33.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 41' ' ' PRO . 6.2 p -116.22 137.92 23.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.661 0.744 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.3 Cg_endo -69.79 102.88 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.695 2.264 . . . . 0.0 112.339 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.74 -47.22 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -53.7 -42.09 67.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -38.55 143.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.89 155.56 86.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.55 0.691 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.91 3.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t 73.19 28.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 114.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 87.53 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -106.49 101.23 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -90.85 170.48 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.496 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -128.24 139.25 52.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.833 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -51.92 147.59 6.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.44 -70.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t 68.61 43.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.889 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -90.36 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.96 138.6 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.532 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 177.52 5.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.398 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -123.14 176.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 131.67 21.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -54.91 -48.85 72.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.49 -62.67 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 48.4 t80 -52.85 131.56 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.96 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -105.51 143.5 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.61 126.03 44.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.628 0.728 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.67 173.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m 61.82 34.82 16.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -115.08 -54.14 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -39.36 151.46 0.21 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.5 2.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 54.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.71 145.06 10.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 96.75 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -81.27 -47.23 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -108.37 -56.13 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.505 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -87.16 99.87 12.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -116.1 43.17 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.24 -82.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.9 p -158.57 130.97 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -85.51 -56.33 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.09 89.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.439 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -176.85 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.3 177.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo -69.68 118.91 5.97 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.4 mm-40 -45.69 -44.06 13.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.95 -62.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 1.7 t80 -56.1 144.03 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 8.2 mm100 -113.05 157.65 21.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.87 125.76 51.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.64 0.733 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 98.66 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.69 2.26 . . . . 0.0 112.353 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.77 166.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.072 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m 58.12 45.52 17.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 34.3 t80 -126.36 100.79 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -148.26 148.85 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -163.63 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.673 2.249 . . . . 0.0 112.409 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -64.97 -25.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.58 142.59 15.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' SER . 53.6 Cg_endo -69.77 2.56 3.43 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 0.0 112.37 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' PRO . 8.4 t -34.75 111.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -81.76 -50.56 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.864 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.452 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -158.18 150.14 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.834 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.9 p -162.99 121.16 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 122.32 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 t -96.36 -61.45 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.2 m -124.1 100.49 6.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.68 99.12 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -105.04 178.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.73 138.73 38.59 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.81 -36.55 82.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -42.04 -46.76 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 56.4 t80 -65.79 158.77 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.9 mm100 -143.37 140.12 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.0 t -73.05 130.27 85.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 160.06 51.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.02 179.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 42' ' ' ALA . 97.5 p -33.37 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 9' ' ' VAL . 1.3 t80 -125.51 -42.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 tm0? -55.64 127.72 67.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.593 0.711 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -179.97 3.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.9 p -83.61 -33.8 25.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.97 145.48 10.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -2.15 9.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' SER . 32.9 t -55.8 130.63 44.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' SER . 4.7 t 35.07 49.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.484 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.1 p -60.56 132.58 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -141.44 122.54 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.1 4.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 m -68.31 115.98 8.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.38 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 t -61.1 -60.57 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 72.87 1.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 172.34 12.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -54.02 177.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.612 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.494 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD11 ' OE1' ' A' ' 12' ' ' GLN . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 44' ' ' TYR . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 114.43 3.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.9 mt-10 -42.81 -45.62 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.57 -62.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -48.85 143.59 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -128.28 137.13 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.58 128.98 84.7 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.617 0.722 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 118.98 6.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.378 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.69 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -81.42 86.26 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 22' ' ' PRO . 55.5 t80 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -75.03 133.63 75.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.615 0.721 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 1.89 4.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.279 . . . . 0.0 112.326 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m 62.82 41.39 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -45.97 153.14 0.88 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -6.01 17.55 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.9 t 64.23 42.46 5.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -133.63 141.36 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.6 p -112.98 111.31 21.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 m -144.37 134.99 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.59 -139.92 4.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 p -56.49 132.37 51.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 t -51.68 -45.47 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.48 -110.4 4.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.325 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -146.59 178.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 12.8 m120 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo -69.78 117.59 5.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -46.17 -45.19 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -39.76 -47.9 2.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 81.4 t80 -62.59 152.73 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.17 141.69 48.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.49 127.01 58.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.718 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 108.34 2.06 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.91 -53.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m -59.18 93.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 2.7 t80 -169.53 131.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -134.14 154.18 79.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.5 Cg_endo -69.8 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.0 t -38.01 -47.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.41 -157.9 44.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 137.32 35.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.756 2.304 . . . . 0.0 112.314 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -71.27 -63.09 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 52' ' ' GLY . 1.2 t -56.74 -56.5 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -90.5 42.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -165.87 137.49 3.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.32 49.26 0.86 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 m -92.83 164.99 13.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.397 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m 58.01 44.23 19.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -46.59 142.81 5.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 174.22 9.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 0.0 112.333 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -99.96 -178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.65 HH12 HG23 ' A' ' 40' ' ' VAL . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.7 133.4 25.57 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' ALA . 7.9 tt0 -53.87 -50.39 66.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.73 -63.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 11' ' ' TRP . 56.0 t80 -58.71 116.18 3.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -105.35 142.16 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG23 HH12 ' A' ' 34' ' ' ARG . 79.0 t -62.36 126.05 87.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 133.32 25.42 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 173.72 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.06 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.6 p 46.16 41.42 8.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.565 ' OH ' HG11 ' A' ' 9' ' ' VAL . 25.3 t80 -125.13 41.28 3.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' TYR . 13.7 tt0 -36.96 120.3 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 174.52 9.42 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -55.45 -43.32 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.94 81.31 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -178.85 2.53 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.706 2.27 . . . . 0.0 112.378 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 t -91.56 149.5 21.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -104.28 150.6 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.515 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -47.9 -53.96 14.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.841 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m -83.9 -57.86 3.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.42 -117.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 t -128.69 155.02 45.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.383 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.8 t -109.11 150.73 27.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.88 167.36 35.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -179.33 2.83 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.676 2.251 . . . . 0.0 112.351 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -74.67 178.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.512 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo -69.82 132.45 23.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -57.69 -41.92 82.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 59.1 t80 -41.59 155.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.29 140.8 51.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.91 123.95 15.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 136.55 33.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.23 -66.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -84.78 131.78 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 50.8 t80 -144.38 128.7 17.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -125.03 115.16 26.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.76 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.733 2.288 . . . . 0.0 112.322 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 m 66.73 45.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -162.96 5.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.61 5.43 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.737 2.291 . . . . 0.0 112.309 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -55.89 -45.69 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -116.21 91.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.48 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.2 p 44.38 42.34 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.854 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -73.22 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.2 66.91 1.73 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -39.19 -45.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.6 t -99.78 95.91 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -43.86 159.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -179.83 3.22 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.55 -176.76 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.527 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.78 137.8 36.27 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.91 -43.8 98.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.63 -49.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -62.07 149.8 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -124.68 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.8 t -101.51 130.86 23.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 162.03 43.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.369 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.96 -178.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 42' ' ' ALA . 37.5 m -33.27 98.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.74 123.17 43.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.52 118.74 74.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.6 Cg_endo -69.75 -173.33 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.662 2.241 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' PRO . 20.5 p -34.95 -53.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.63 89.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.55 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.71 2.274 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -113.19 -52.32 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.6 t -87.29 83.21 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.461 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.865 0.364 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 35.4 m-80 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.515 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.351 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.55 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 12' ' ' GLN . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.919 0.39 . . . . 0.0 111.092 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 28' ' ' GLU . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.853 0.358 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.562 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 40.6 m-80 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.562 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.889 0.376 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.573 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' OE1' HD11 ' A' ' 19' ' ' ILE . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.477 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.881 0.372 . . . . 0.0 111.121 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.518 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.442 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.491 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.844 0.354 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.905 0.384 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.881 0.372 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo . . . . . 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.612 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.494 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD11 ' OE1' ' A' ' 12' ' ' GLN . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.852 0.358 . . . . 0.0 111.155 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 43.0 m-80 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.845 0.355 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.52 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.52 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.868 0.366 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.512 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.527 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -110.76 131.11 55.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.363 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -82.71 115.85 21.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 75.25 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.449 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 p -125.91 38.45 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.853 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -56.11 -50.34 71.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 52.38 -157.74 3.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 172.06 13.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.649 2.233 . . . . 0.0 112.381 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -175.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 74.04 150.78 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.2 p-90 -93.01 121.33 34.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.15 114.77 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -42.71 126.66 3.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.1 Cg_endo -69.76 5.34 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.743 2.295 . . . . 0.0 112.358 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.2 -46.64 0.21 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.1 p -112.63 6.19 18.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 66.4 p 44.6 44.27 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.0 t80 -97.03 87.49 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 12.4 mm -33.1 92.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' PHE . 35.4 m-80 -91.63 136.69 32.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -43.84 147.8 0.83 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.563 0.697 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.5 Cg_endo -69.77 -1.67 8.87 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.5 p -105.52 -16.36 14.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 18.5 ttt-85 -100.3 102.86 19.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.612 0.72 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.0 Cg_endo -69.78 3.73 2.61 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.68 166.94 20.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -96.85 162.85 13.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.4 tp10 -104.96 -40.05 6.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.8 mmt -70.12 -77.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.3 p -92.46 16.56 11.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' CYS . 34.4 t 34.53 32.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 30' ' ' CYS . 57.8 ttm-85 -77.16 116.34 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.59 150.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.061 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 12.2 ttp180 -74.74 139.75 74.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.651 0.738 . . . . 0.0 110.832 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.1 Cg_endo -69.76 103.96 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -40.75 -46.9 2.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.06 -49.32 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 35.9 t80 -45.51 161.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.5 pm0 -129.44 131.24 46.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG23 ' HD2' ' A' ' 41' ' ' PRO . 3.8 p -108.41 137.6 19.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.8 91.53 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.663 2.242 . . . . 0.0 112.364 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.97 164.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 m 62.73 39.11 11.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 34.0 t80 -107.25 148.01 29.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -132.23 157.07 79.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.11 2.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.2 m 62.06 45.13 7.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.66 160.92 43.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 165.38 31.13 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.359 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 -177.29 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m 57.48 43.97 22.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.535 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -59.58 160.16 7.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.9 p -139.77 114.82 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -128.85 1.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.434 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.1 p -69.6 171.19 9.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.837 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 m -113.01 117.89 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.86 -83.49 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 175.93 7.42 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.7 2.267 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.612 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -125.64 179.82 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.83 159.08 30.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 62.2 p-90 -98.35 116.08 29.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -63.24 116.86 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -44.93 126.99 5.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.639 0.733 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.76 5.62 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.709 2.272 . . . . 0.0 112.305 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.61 -47.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -111.49 2.28 17.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 70.9 p 49.32 40.12 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 75.9 t80 -92.93 87.07 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.4 mm -32.93 96.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.106 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.8 m-80 -97.18 129.58 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -39.38 149.03 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -6.34 18.35 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.343 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -96.45 -22.43 17.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -98.81 103.23 18.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.51 164.96 19.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.17 162.99 13.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.5 tm-20 -106.09 -40.67 5.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.62 -77.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.8 p -92.63 18.33 8.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' CYS . 26.5 p 36.64 29.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 30' ' ' CYS . 18.4 ttm180 -73.21 118.15 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.34 133.29 16.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 48.9 ttp180 -52.32 140.37 34.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.76 148.97 66.21 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -69.15 -43.66 73.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -40.43 -45.49 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 89.0 t80 -62.07 162.92 8.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -147.25 151.72 37.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' HD2' ' A' ' 41' ' ' PRO . 94.4 t -97.44 133.25 23.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.602 0.715 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD2' HG13 ' A' ' 40' ' ' VAL . 54.1 Cg_endo -69.72 -177.57 1.92 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.742 2.295 . . . . 0.0 112.381 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.58 157.26 17.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.151 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m 49.93 42.74 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' OH ' HG11 ' A' ' 9' ' ' VAL . 1.4 t80 -115.45 -51.44 2.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -49.44 139.71 14.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 158.66 56.16 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.658 2.239 . . . . 0.0 112.361 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.8 p -46.26 -43.25 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.69 67.52 2.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.48 54.14 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.317 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 m -55.37 140.69 38.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.4 p -139.04 175.25 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -75.17 136.43 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.36 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -46.11 -53.24 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.86 -155.44 25.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -114.77 86.82 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.873 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t -88.81 112.61 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.86 -151.76 5.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -179.04 2.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.373 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -90.99 177.33 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 153.31 28.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.5 p-90 -94.06 119.48 32.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 0.0 110.873 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.43 115.0 4.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -44.67 127.45 5.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.637 0.732 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.7 Cg_endo -69.76 5.71 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.633 2.222 . . . . 0.0 112.359 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.46 -48.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.3 p -109.24 -0.09 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 43.7 p 50.4 42.14 25.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 88.6 t80 -96.56 86.13 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 21.7 mm -33.06 93.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.0 m-80 -92.5 131.07 37.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ASN . 96.6 mttt -37.83 147.37 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.78 -0.44 6.94 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -103.46 -19.21 14.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 31.7 ttt180 -97.87 105.04 24.72 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.623 0.725 . . . . 0.0 110.851 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.3 Cg_endo -69.83 3.67 2.67 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.41 167.56 21.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -94.27 162.63 13.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.731 0.301 . . . . 0.0 110.914 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 42.8 tt0 -106.14 -39.82 5.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.58 -77.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -91.77 17.78 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' CYS . 24.5 t 34.54 32.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' CYS . 15.8 ttt85 -80.51 111.92 17.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.55 148.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 50.0 ttp85 -72.32 139.72 81.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.616 0.722 . . . . 0.0 110.857 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.2 Cg_endo -69.72 126.83 13.8 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.319 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.96 -43.34 95.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.76 -47.87 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 14.2 t80 -64.15 151.91 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 13.8 pt20 -117.94 144.56 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG23 ' HD2' ' A' ' 41' ' ' PRO . 5.5 p -122.62 137.1 27.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.749 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.74 110.68 2.61 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.661 2.241 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.75 162.05 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 t 60.13 39.38 19.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 45' ' ' GLN . 30.3 t80 -64.14 150.59 45.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 44' ' ' TYR . 6.8 mp0 -99.68 156.7 35.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.45 3.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.677 2.251 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m 65.17 45.5 2.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.51 137.55 15.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -29.12 24.59 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.715 2.276 . . . . 0.0 112.344 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 t -89.87 42.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.6 p -99.5 -50.9 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.417 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -106.04 129.49 54.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -149.67 166.09 30.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.75 179.81 16.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.436 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -49.44 -44.63 45.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -88.34 153.5 21.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 177.46 20.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 176.35 6.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.99 178.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.57 157.26 31.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.55 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 63.0 p-90 -98.33 115.95 29.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.7 tt0 -65.11 114.16 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.2 t -41.76 127.7 2.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.616 0.722 . . . . 0.0 110.839 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.0 Cg_endo -69.74 5.62 1.62 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 0.0 112.371 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.58 -47.94 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.6 p -111.49 4.78 19.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.92 0.391 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.8 p 47.1 38.41 6.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' ASN . 76.6 t80 -90.24 87.58 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 12' ' ' GLN . 20.8 mm -34.03 94.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.2 m-80 -94.15 131.41 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -39.91 148.92 0.3 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.719 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -8.14 22.85 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -96.55 -21.74 17.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NH1' ' HB2' ' A' ' 28' ' ' GLU . 5.8 ttm180 -100.89 100.91 13.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.574 0.702 . . . . 0.0 110.83 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.72 3.93 2.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.693 2.262 . . . . 0.0 112.354 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.05 160.08 16.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -94.29 162.28 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 27.8 tt0 -105.99 -41.36 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.7 mmt -67.13 -76.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -93.38 18.77 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 5.7 t 33.65 34.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 30' ' ' CYS . 32.0 ttt85 -79.22 112.07 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.4 136.29 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 55.8 ttp180 -57.91 138.28 83.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.71 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.455 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.6 Cg_endo -69.77 147.68 63.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.332 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 37' ' ' ALA . 4.3 mp0 -68.55 -45.1 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.93 -47.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.087 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 13.9 t80 -73.81 138.37 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.47 164.18 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 41' ' ' PRO . 96.3 t -85.48 132.11 45.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.8 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.89 170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 54.5 42.0 31.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -125.64 83.46 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -153.69 153.07 28.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.578 0.704 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 178.28 4.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.294 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 2.5 t -74.85 78.27 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HD2' ' A' ' 49' ' ' PRO . . . -97.12 103.55 2.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.477 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD2' ' HA2' ' A' ' 48' ' ' GLY . 54.3 Cg_endo -69.76 -50.66 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -115.33 42.84 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m 47.89 42.41 16.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.529 -0.229 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 t -74.07 88.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -83.41 -45.51 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.59 55.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.9 p -66.85 -45.59 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.1 m -84.25 102.07 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.3 78.69 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -116.03 -178.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.092 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 79.37 154.92 8.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.582 ' NE1' ' NE ' ' A' ' 34' ' ' ARG . 46.1 p-90 -93.56 122.5 36.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.721 0.296 . . . . 0.0 110.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -66.63 110.27 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.38 125.75 1.1 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.596 0.712 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 5.06 1.86 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.01 -42.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.542 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.3 p -116.38 2.17 13.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 64.1 p 49.2 41.43 19.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 28' ' ' GLU . 84.9 t80 -94.9 87.19 4.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 16.7 mm -33.31 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 51.7 m-80 -94.38 134.85 36.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -43.82 147.51 0.86 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.604 0.716 . . . . 0.0 110.91 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -1.37 8.3 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.715 2.277 . . . . 0.0 112.391 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.7 p -103.26 -18.13 15.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -92.32 108.77 33.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 2.56 3.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.86 173.63 22.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -95.88 164.13 12.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.329 . . . . 0.0 110.848 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 55.5 tt0 -104.99 -40.15 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 29.0 mmt -68.35 -77.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.7 p -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 67.7 m 34.21 33.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' CYS . 42.5 ttm-85 -78.76 116.86 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.82 151.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.582 ' NE ' ' NE1' ' A' ' 11' ' ' TRP . 15.2 ttm180 -74.31 141.29 76.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.693 . . . . 0.0 110.908 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.1 Cg_endo -69.73 131.89 22.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.677 2.252 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.9 mp0 -64.41 -50.15 68.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.82 -53.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 15.1 t80 -45.74 156.53 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.579 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 1.3 mp0 -124.48 142.59 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 41' ' ' PRO . 3.3 p -137.12 136.31 20.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.61 0.719 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.9 Cg_endo -69.73 110.28 2.51 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 44' ' ' TYR . . . -52.23 -57.33 10.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.7 m -37.72 -29.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 1.7 t80 -60.9 132.08 52.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -122.39 152.48 61.13 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.595 0.712 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.64 45.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.6 p -60.69 -45.03 95.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.3 142.23 2.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 110.06 2.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.713 2.275 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 p -91.45 -46.73 7.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -130.65 130.94 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.459 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -163.53 119.65 1.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 0.0 110.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.6 p -157.72 141.63 15.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.38 132.94 48.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 p -61.4 117.14 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.03 -45.68 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.92 156.1 7.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -178.92 2.56 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.281 . . . . 0.0 112.347 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.67 179.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 87.3 155.52 28.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.562 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 54.8 p-90 -94.66 123.68 38.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.665 0.269 . . . . 0.0 110.961 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -68.34 113.48 5.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.3 t -41.4 127.33 2.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.634 0.73 . . . . 0.0 110.915 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 5.6 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.69 -48.03 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.9 p -108.66 -0.73 19.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.969 0.414 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.5 p 50.6 40.36 23.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 81.6 t80 -94.22 87.38 5.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 18' ' ' PHE . 15.4 mm -33.33 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 40.6 m-80 -91.99 135.19 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -41.65 147.29 0.51 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.575 0.702 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 1.41 4.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.0 p -104.68 -23.1 13.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttt85 -96.35 104.48 17.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.64 2.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 173.39 17.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -104.24 163.07 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.894 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 48.7 tt0 -105.38 -39.75 6.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mmt -69.01 -76.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.5 p -95.42 18.14 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' CYS . 76.6 m 33.03 35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 30' ' ' CYS . 43.6 ttm-85 -79.16 115.63 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -35.89 149.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.114 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.562 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 9.6 ttp180 -74.27 140.08 76.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 110.883 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 110.25 2.5 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -41.17 -44.66 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.2 -59.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -43.97 148.92 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -119.25 145.44 46.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 41' ' ' PRO . 95.2 t -93.25 138.94 22.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.577 0.703 . . . . 0.0 111.163 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.77 89.88 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.632 2.221 . . . . 0.0 112.398 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -35.67 -43.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.1 m -86.48 83.6 7.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 45' ' ' GLN . 12.2 t80 -129.38 40.01 3.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 48.8 tt0 -36.21 98.95 0.17 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.613 0.72 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.9 Cg_endo -69.8 -179.33 2.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 0.0 112.324 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 t -81.14 47.61 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.15 -82.98 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 175.78 7.61 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.685 2.257 . . . . 0.0 112.375 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t 50.51 41.77 25.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -80.49 -56.89 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.493 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -47.06 -44.33 20.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.882 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -40.88 158.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.77 -102.33 1.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.4 p -119.5 156.32 30.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.858 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 m -110.55 -48.26 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.63 84.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 178.85 4.15 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.72 178.74 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.11 154.23 10.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.573 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.2 p-90 -94.3 119.86 33.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.738 0.304 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' OE1' HD11 ' A' ' 19' ' ' ILE . 3.7 tt0 -67.81 113.71 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -41.84 125.94 2.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 5.68 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.67 -47.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.0 p -110.64 0.05 17.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 69.7 p 50.13 41.35 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.7 t80 -95.27 87.01 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.4 mm -33.46 93.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 18' ' ' PHE . 48.3 m-80 -93.97 133.78 37.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -41.15 149.31 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.81 -10.16 27.84 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.729 2.286 . . . . 0.0 112.314 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -93.74 -18.0 22.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 14.6 ttm-85 -103.89 100.63 21.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.284 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.08 160.93 17.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -93.08 162.33 14.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 tt0 -105.88 -41.72 5.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.4 mmm -66.99 -76.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -94.53 18.29 11.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' CYS . 21.6 t 32.65 36.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.477 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 24.3 ttt85 -81.98 110.44 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.86 145.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 17.3 ttp180 -71.66 142.94 86.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.87 148.55 64.59 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.646 2.231 . . . . 0.0 112.308 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -72.3 -42.53 65.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.13 -47.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CZ ' ' O ' ' A' ' 39' ' ' GLN . 37.2 t80 -67.47 152.92 44.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' O ' ' CZ ' ' A' ' 38' ' ' TYR . 14.8 pt20 -130.59 169.0 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.42 129.95 26.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.686 0.755 . . . . 0.0 111.158 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 177.2 5.81 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 2.283 . . . . 0.0 112.32 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -94.73 -51.73 4.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 42' ' ' ALA . 68.9 m -34.9 -50.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 23.3 m-85 -62.15 -48.23 81.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 5.0 pt20 -158.14 150.52 17.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.739 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.658 2.239 . . . . 0.0 112.358 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -64.42 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.33 -103.77 2.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.17 6.49 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.358 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -85.34 86.38 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.839 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.5 p -152.99 144.28 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.48 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -110.28 144.23 39.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -67.52 -57.82 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.0 160.23 23.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.2 p -85.61 136.0 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 t -97.55 112.91 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.61 97.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.498 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -176.64 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.674 2.249 . . . . 0.0 112.321 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -55.68 178.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 85.33 154.55 22.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 56.5 p-90 -94.44 117.24 29.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.867 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -61.68 114.19 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 t -43.23 126.73 3.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 0.0 110.874 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 54.3 Cg_endo -69.7 5.83 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.402 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.78 -49.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -108.79 1.27 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 110.866 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 71.8 p 49.2 42.7 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.0 t80 -96.51 87.08 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 18.8 mm -33.09 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.4 m-80 -94.58 132.51 39.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -40.3 147.78 0.36 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 110.929 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -1.75 9.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.373 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.0 p -101.25 -19.45 15.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.5 ttm-85 -101.05 103.13 23.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.55 2.71 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.633 2.222 . . . . 0.0 112.343 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.65 166.66 18.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.482 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -97.25 162.63 13.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.6 tt0 -106.11 -41.99 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmm -67.58 -76.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.0 p -92.91 17.42 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 30.1 p 33.99 33.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 36.5 ttt85 -79.36 117.96 20.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.77 149.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -72.94 141.42 81.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.572 0.701 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.8 Cg_endo -69.75 126.17 13.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.68 2.254 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 37' ' ' ALA . 3.3 tp10 -55.02 -52.52 62.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.96 -51.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 71.6 t80 -44.52 160.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 32.0 mt-30 -135.33 129.37 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.76 126.28 28.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.727 . . . . 0.0 111.089 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 116.22 4.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.633 2.222 . . . . 0.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.68 87.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -78.69 49.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 9' ' ' VAL . 56.8 t80 -129.4 38.73 3.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 35.7 tt0 -86.24 139.68 34.3 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 45' ' ' GLN . 54.1 Cg_endo -69.76 -174.16 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.325 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 48' ' ' GLY . 51.3 p -84.6 36.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' SER . . . 36.47 75.63 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -41.31 4.42 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.385 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 t -106.07 148.21 28.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -102.78 104.99 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.479 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -157.42 112.54 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -150.31 126.53 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.89 67.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.9 m -63.31 118.81 8.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 p -150.4 128.38 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.2 85.34 0.61 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 0.0 112.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -112.89 178.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.126 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.16 153.24 22.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.518 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.4 p-90 -92.15 120.09 32.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.735 0.302 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 4.0 tt0 -70.18 112.37 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.0 t -38.58 127.3 1.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 5.89 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.33 -49.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 18.9 p -109.86 5.65 22.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.442 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 74.1 p 46.66 38.64 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' ILE . 84.1 t80 -90.0 88.8 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.7 mm -34.61 98.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.69 131.57 44.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -42.87 149.59 0.49 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -1.74 9.02 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.8 p -102.6 -19.97 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 17.8 ttm-85 -99.86 101.59 14.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 54.2 Cg_endo -69.75 4.66 2.06 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.14 163.95 21.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -95.27 163.4 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tp10 -106.01 -40.59 5.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.8 mmt -68.18 -76.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.7 p -93.04 16.91 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.4 m 37.07 29.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.491 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 20.2 ttm180 -73.63 120.97 19.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.5 146.46 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 51.1 ttp180 -64.24 139.4 97.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.562 0.696 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.4 Cg_endo -69.77 145.29 56.6 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.76 2.307 . . . . 0.0 112.314 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.0 tp10 -62.67 -51.4 67.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.07 -62.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.068 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 79.1 t80 -54.13 140.31 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -125.73 143.34 51.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG13 ' HD2' ' A' ' 41' ' ' PRO . 90.0 t -90.98 135.99 28.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.614 0.721 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG13 ' A' ' 40' ' ' VAL . 53.8 Cg_endo -69.76 158.97 55.14 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.359 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.25 149.4 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 t 50.24 42.06 25.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.585 ' OH ' HG11 ' A' ' 9' ' ' VAL . 40.9 t80 -81.48 -46.89 13.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 5.9 tt0 -122.15 114.58 30.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.5 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.312 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.7 p -44.3 -42.06 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.15 178.76 0.55 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 105.51 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.685 2.257 . . . . 0.0 112.319 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.8 p -90.66 156.0 18.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.4 m -93.04 150.77 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -145.66 170.66 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 143.78 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.08 69.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.1 m -65.93 -44.38 85.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 p -83.59 140.67 32.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.02 143.92 18.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.54 2.38 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.29 178.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.35 158.8 30.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 63.3 p-90 -99.15 117.91 34.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.2 tt0 -66.68 115.84 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -43.6 126.91 3.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.732 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 5.3 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.73 2.286 . . . . 0.0 112.351 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.71 -46.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.4 p -113.49 4.85 16.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 67.7 p 46.85 38.87 6.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.119 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 87.7 t80 -91.29 87.19 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' PHE . 19.4 mm -33.45 95.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.5 m-80 -96.16 132.33 41.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -39.66 149.18 0.28 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.603 0.716 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.2 Cg_endo -69.81 -12.28 32.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.673 2.249 . . . . 0.0 112.32 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 p -92.14 -22.81 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 5.5 ttm180 -100.73 100.67 13.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.73 2.59 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.711 2.274 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.4 159.69 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -93.13 162.39 14.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.887 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 9.6 tp10 -105.61 -40.3 5.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.5 mmt -68.61 -77.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.0 p -92.45 18.6 8.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' CYS . 57.8 m 33.63 34.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 30' ' ' CYS . 35.6 ttm-85 -80.49 118.28 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.94 146.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.5 ttp180 -71.78 140.58 83.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 0.0 110.945 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.05 69.15 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.716 2.278 . . . . 0.0 112.355 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 mm-40 -78.61 -42.46 28.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -37.08 -55.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 37.1 t80 -54.47 160.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 34.9 mt-30 -136.73 143.86 43.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG13 ' HD2' ' A' ' 41' ' ' PRO . 67.1 t -80.32 133.48 56.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.632 0.729 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 53.5 Cg_endo -69.84 130.05 18.58 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.29 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 m -82.88 38.82 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' CB ' ' HG2' ' A' ' 41' ' ' PRO . 24.0 t80 -101.04 -39.98 7.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -60.35 132.73 90.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.551 0.691 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 7.11 1.05 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.713 2.276 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 m 74.92 52.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.94 -145.12 11.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 168.38 21.77 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -38.51 -44.47 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.9 t -166.56 141.88 4.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.533 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -47.34 -55.04 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.9 p -170.38 164.58 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.69 175.31 18.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.435 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -95.16 161.35 14.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.797 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -107.49 103.74 13.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.83 -156.29 14.49 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.07 8.58 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.334 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.67 178.45 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.64 154.0 24.51 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.517 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.1 p-90 -94.21 118.46 31.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -64.29 116.42 6.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 1.8 t -44.49 126.52 4.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.576 0.703 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.81 5.55 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.0 -47.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.469 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.4 p -112.71 3.3 16.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.0 p 49.03 39.35 14.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 20' ' ' ASN . 80.3 t80 -91.13 87.14 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 18' ' ' PHE . 22.6 mm -32.73 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' PHE . 44.2 m-80 -93.29 132.75 37.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -44.41 148.25 0.9 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.539 0.685 . . . . 0.0 110.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' HG21 ' A' ' 40' ' ' VAL . 53.7 Cg_endo -69.78 3.25 2.89 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.367 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.572 ' CG2' ' CE1' ' A' ' 44' ' ' TYR . 39.3 p -106.63 -24.74 12.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 11.2 ttt85 -93.87 106.12 20.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.586 0.707 . . . . 0.0 110.867 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.75 3.79 2.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.58 171.7 20.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -98.9 162.58 13.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.9 tm-20 -105.74 -40.31 5.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mmt -68.2 -77.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.9 p -93.37 17.9 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.7 p 34.14 35.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.1 ttm180 -80.08 117.32 20.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.63 147.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.517 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 24.2 ttp180 -69.98 140.06 88.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 0.0 110.833 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.82 129.92 18.37 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.69 -45.45 92.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.7 -50.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 70.3 t80 -60.38 159.94 9.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 6.9 pt20 -127.23 141.4 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.619 HG23 ' HD2' ' A' ' 41' ' ' PRO . 7.3 p -127.31 137.93 31.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.651 0.738 . . . . 0.0 111.115 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.619 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.5 Cg_endo -69.84 107.09 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.16 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 p -81.43 44.67 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.572 ' CE1' ' CG2' ' A' ' 23' ' ' THR . 54.9 t80 -81.17 -59.08 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -124.25 113.19 27.93 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -179.17 2.74 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 0.0 112.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.6 m -39.11 -46.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 158.93 33.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -23.78 30.38 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -168.5 131.51 1.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 t -114.25 140.48 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.446 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.6 p -82.76 42.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -122.63 -39.85 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.9 59.26 0.54 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.3 t -87.86 92.48 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 t -55.15 -59.98 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.62 86.67 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 178.3 4.72 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.72 179.08 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.44 160.06 34.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.524 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 62.3 p-90 -99.72 118.67 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -65.88 117.03 7.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.1 t -46.31 126.07 7.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.9 Cg_endo -69.73 5.14 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.33 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.73 -45.96 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 14.8 p -113.42 1.31 15.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 78.7 p 50.18 42.34 25.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.446 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 82.1 t80 -96.76 87.0 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 20.0 mm -33.35 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' PHE . 58.9 m-80 -95.97 131.28 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 20' ' ' ASN . 7.5 mtmp? -37.89 148.58 0.22 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.73 31.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.648 2.232 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.1 p -92.22 -24.1 19.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 13.9 ttm-85 -99.43 101.3 12.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.908 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.7 Cg_endo -69.73 3.48 2.73 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.351 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.48 158.0 15.65 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -91.33 162.52 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.848 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 tm-20 -106.22 -42.56 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.0 mmt -65.89 -77.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.85 17.73 10.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' CYS . 90.4 m 33.57 35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 14.6 ttt-85 -84.01 109.92 18.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.16 146.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 46.9 ttp180 -70.86 141.15 86.76 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.599 0.714 . . . . 0.0 110.902 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 53.3 Cg_endo -69.8 120.64 7.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 37' ' ' ALA . 56.8 mt-10 -50.59 -45.61 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -36.5 -58.89 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 7.5 t80 -53.22 128.83 29.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -94.55 137.73 33.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG23 ' HD2' ' A' ' 41' ' ' PRO . 6.2 p -116.22 137.92 23.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.661 0.744 . . . . 0.0 111.137 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 40' ' ' VAL . 53.3 Cg_endo -69.79 102.88 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.695 2.264 . . . . 0.0 112.339 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.74 -47.22 74.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -53.7 -42.09 67.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -38.55 143.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.89 155.56 86.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.55 0.691 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.91 3.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t 73.19 28.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 114.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 87.53 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.686 2.257 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -106.49 101.23 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -90.85 170.48 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.496 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -128.24 139.25 52.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 0.0 110.833 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -51.92 147.59 6.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.44 -70.97 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t 68.61 43.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.889 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.6 m -90.36 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.96 138.6 9.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.532 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 177.52 5.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.241 . . . . 0.0 112.398 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -123.14 176.93 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.23 155.9 22.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 56.1 p-90 -93.16 127.39 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -71.93 116.63 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -45.57 126.91 6.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.574 0.702 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 5.88 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.52 -48.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.445 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.428 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.5 p -108.2 -1.48 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.884 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 56.5 p 51.29 41.22 27.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' ASN . 78.5 t80 -95.15 87.16 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 20.4 mm -34.0 92.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.1 m-80 -93.89 133.78 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.45 152.42 0.34 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -17.39 37.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.311 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.5 p -85.03 -20.49 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 11.0 ttt-85 -100.94 100.02 11.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.631 0.729 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.9 2.5 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.703 2.269 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.81 170.3 16.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.495 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.94 162.11 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.3 . . . . 0.0 110.912 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 25.5 tt0 -105.69 -40.34 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.12 -77.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 32' ' ' ARG . 29.1 p -93.82 18.7 9.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 30' ' ' CYS . 31.3 p 33.14 35.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 30' ' ' CYS . 38.8 ttm-85 -80.44 119.28 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.37 145.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 47.1 ttp180 -70.45 140.11 87.16 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 131.67 21.69 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.645 2.23 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -54.91 -48.85 72.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.49 -62.67 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 48.4 t80 -52.85 131.56 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.96 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -105.51 143.5 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.61 126.03 44.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.628 0.728 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.67 173.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m 61.82 34.82 16.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.857 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -115.08 -54.14 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -39.36 151.46 0.21 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.5 2.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 54.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.71 145.06 10.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 96.75 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -81.27 -47.23 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -108.37 -56.13 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.505 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -87.16 99.87 12.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.8 p -116.1 43.17 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.24 -82.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.9 p -158.57 130.97 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -85.51 -56.33 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.09 89.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.439 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -176.85 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.3 177.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 155.79 20.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 57.4 p-90 -95.53 125.79 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.95 115.76 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.8 t -44.5 126.47 4.84 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.635 0.731 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 5.95 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.35 -49.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.8 p -109.25 1.95 20.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 58.7 p 49.13 41.59 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 20' ' ' ASN . 77.6 t80 -95.2 87.96 5.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' PHE . 23.2 mm -34.41 93.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.159 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' PHE . 56.1 m-80 -94.12 131.48 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -41.14 152.08 0.26 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.548 0.689 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 53.7 Cg_endo -69.76 -16.36 37.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.373 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.6 p -86.29 -20.87 27.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.74 99.66 12.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 3.97 2.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.5 168.26 15.7 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.454 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.75 162.13 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 110.912 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 13.7 tm-20 -105.17 -40.32 5.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.2 mtt -69.25 -77.4 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' ARG . 28.9 p -93.19 17.31 11.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 8.5 t 33.21 35.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 25.6 ttt85 -80.88 115.82 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.85 147.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 36.5 ttp180 -73.93 142.51 79.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.4 Cg_endo -69.68 118.91 5.97 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.4 mm-40 -45.69 -44.06 13.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -34.95 -62.0 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CE1' ' O ' ' A' ' 39' ' ' GLN . 1.7 t80 -56.1 144.03 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' CE1' ' A' ' 38' ' ' TYR . 8.2 mm100 -113.05 157.65 21.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.87 125.76 51.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.64 0.733 . . . . 0.0 111.132 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 98.66 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.69 2.26 . . . . 0.0 112.353 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.77 166.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.072 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m 58.12 45.52 17.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 34.3 t80 -126.36 100.79 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.913 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -148.26 148.85 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.923 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -163.63 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.673 2.249 . . . . 0.0 112.409 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.5 m -64.97 -25.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -121.58 142.59 15.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' SER . 53.6 Cg_endo -69.77 2.56 3.43 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 0.0 112.37 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' PRO . 8.4 t -34.75 111.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -81.76 -50.56 9.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.864 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.452 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -158.18 150.14 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 0.0 110.834 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.9 p -162.99 121.16 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.05 122.32 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 t -96.36 -61.45 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.2 m -124.1 100.49 6.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.68 99.12 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 179.24 3.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -105.04 178.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.48 155.85 27.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.433 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 58.2 p-90 -94.82 118.01 31.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -63.42 114.67 4.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -42.48 126.96 2.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.72 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 5.45 1.68 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.661 2.241 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.38 -47.0 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 15.7 p -112.05 3.12 17.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.912 0.387 . . . . 0.0 110.841 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.2 p 48.3 40.79 15.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 70.1 t80 -93.24 86.84 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' PHE . 27.3 mm -32.96 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' PHE . 57.4 m-80 -95.67 132.61 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -40.21 147.82 0.35 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.565 0.697 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.69 7.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.8 p -103.42 -21.31 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -98.69 103.06 16.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.559 0.695 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.8 3.92 2.51 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.711 2.274 . . . . 0.0 112.352 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.85 169.61 16.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -101.34 162.3 12.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.917 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 8.8 tp10 -105.24 -39.26 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.9 mmt -70.05 -77.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 32' ' ' ARG . 31.7 p -92.79 17.68 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' CYS . 28.1 p 34.2 33.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 37.3 ttt85 -78.57 119.93 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.92 145.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 21.9 ttp180 -69.2 141.0 91.01 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.589 0.709 . . . . 0.0 110.915 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.5 Cg_endo -69.73 138.73 38.59 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.733 2.289 . . . . 0.0 112.311 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.81 -36.55 82.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -42.04 -46.76 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' GLN . 56.4 t80 -65.79 158.77 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' TYR . 3.9 mm100 -143.37 140.12 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.0 t -73.05 130.27 85.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.601 0.715 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 160.06 51.07 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 0.0 112.357 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.02 179.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 42' ' ' ALA . 97.5 p -33.37 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 9' ' ' VAL . 1.3 t80 -125.51 -42.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 tm0? -55.64 127.72 67.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.593 0.711 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -179.97 3.3 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.9 p -83.61 -33.8 25.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.97 145.48 10.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -2.15 9.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' SER . 32.9 t -55.8 130.63 44.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' SER . 4.7 t 35.07 49.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.484 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.1 p -60.56 132.58 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -141.44 122.54 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.1 4.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 m -68.31 115.98 8.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.38 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 t -61.1 -60.57 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 72.87 1.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 172.34 12.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -54.02 177.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.083 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.13 153.6 17.46 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' ' 34' ' ' ARG . 60.4 p-90 -99.85 116.6 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.91 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.612 ' OE1' HD11 ' A' ' 19' ' ' ILE . 2.1 tt0 -65.01 112.26 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.0 t -37.92 127.68 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 0.0 110.861 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 5.45 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.693 2.262 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.66 -48.01 0.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.512 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 29.5 p -112.27 9.32 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.897 0.379 . . . . 0.0 110.897 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.494 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 29.8 p 47.03 44.15 14.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t80 -95.36 107.59 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD11 ' OE1' ' A' ' 12' ' ' GLN . 24.9 mm -53.55 84.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 18' ' ' PHE . 50.2 m-80 -85.84 129.83 34.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -39.5 150.16 0.25 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 44' ' ' TYR . 53.6 Cg_endo -69.79 -13.07 34.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.0 p -92.51 -18.29 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.179 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 14.7 ttm-85 -98.36 102.15 13.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 110.857 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.5 Cg_endo -69.82 3.65 2.68 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.74 174.91 17.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -106.39 163.32 12.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.765 0.316 . . . . 0.0 110.942 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 23.9 tt0 -103.19 -40.03 6.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.7 mmt -70.78 -77.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 32' ' ' ARG . 27.8 p -95.15 16.12 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.2 p 33.67 34.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 30' ' ' CYS . 34.0 ttt180 -75.16 112.07 11.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -33.35 138.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.164 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 58.5 ttp85 -60.81 140.78 93.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.77 114.43 3.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 37' ' ' ALA . 41.9 mt-10 -42.81 -45.62 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -35.57 -62.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -48.85 143.59 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -128.28 137.13 51.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.58 128.98 84.7 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.617 0.722 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 118.98 6.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.378 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.41 -46.69 18.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -81.42 86.26 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 22' ' ' PRO . 55.5 t80 -144.64 129.83 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -75.03 133.63 75.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.615 0.721 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 1.89 4.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.279 . . . . 0.0 112.326 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m 62.82 41.39 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -45.97 153.14 0.88 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -6.01 17.55 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.9 t 64.23 42.46 5.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.1 p -133.63 141.36 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.6 p -112.98 111.31 21.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.0 m -144.37 134.99 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.59 -139.92 4.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.45 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 p -56.49 132.37 51.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 t -51.68 -45.47 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.48 -110.4 4.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 171.74 13.96 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.325 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -146.59 178.17 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 20' ' ' ASN . . . 83.56 154.68 18.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.532 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.516 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 53.2 p-90 -94.54 129.02 41.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.58 115.18 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.7 t -42.0 126.03 2.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.5 Cg_endo -69.82 4.64 2.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.31 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.67 -48.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 18' ' ' PHE . 30.3 p -112.35 12.35 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 13.1 p 43.99 54.34 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.8 t80 -106.31 105.27 15.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 15.2 mm -54.7 82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 18' ' ' PHE . 43.0 m-80 -83.71 135.14 34.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -43.61 152.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.711 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 54.1 Cg_endo -69.78 -19.16 36.4 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.656 2.237 . . . . 0.0 112.369 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -85.04 -18.21 35.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -99.9 101.17 13.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.721 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 4.68 2.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.23 . . . . 0.0 112.341 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.96 177.44 17.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -106.53 163.03 13.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 62.4 tt0 -103.34 -39.9 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.1 mmt -70.63 -77.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' CYS . 32.0 p -94.24 14.8 19.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 30' ' ' CYS . 16.9 t 34.26 36.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.3 ttt85 -77.11 110.08 11.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -32.65 134.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 33.5 ttp180 -56.73 140.59 75.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.569 0.699 . . . . 0.0 110.847 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 53.6 Cg_endo -69.78 117.59 5.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -46.17 -45.19 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -39.76 -47.9 2.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 11' ' ' TRP . 81.4 t80 -62.59 152.73 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.17 141.69 48.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.49 127.01 58.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.609 0.718 . . . . 0.0 111.113 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 108.34 2.06 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.91 -53.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 m -59.18 93.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 2.7 t80 -169.53 131.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -134.14 154.18 79.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.5 Cg_endo -69.8 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.0 t -38.01 -47.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.41 -157.9 44.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 137.32 35.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.756 2.304 . . . . 0.0 112.314 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -71.27 -63.09 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 52' ' ' GLY . 1.2 t -56.74 -56.5 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -90.5 42.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -165.87 137.49 3.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.32 49.26 0.86 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 m -92.83 164.99 13.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.397 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m 58.01 44.23 19.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -46.59 142.81 5.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 174.22 9.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.72 2.28 . . . . 0.0 112.333 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -99.96 -178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 155.25 18.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 60.7 p-90 -93.09 117.61 30.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.8 tt0 -65.38 113.46 4.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.3 t -41.02 127.02 2.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.74 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.14 -47.68 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 17.5 p -111.85 3.67 17.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.7 p 48.74 37.69 10.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CB ' ' SG ' ' A' ' 16' ' ' CYS . 84.3 t80 -89.46 87.49 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 28.5 mm -33.32 97.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' PHE . 53.0 m-80 -97.12 131.77 43.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -43.0 149.19 0.52 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.541 0.686 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 53.8 Cg_endo -69.76 -0.02 6.31 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.676 2.251 . . . . 0.0 112.349 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -102.92 -23.68 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -98.64 102.39 14.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.618 0.723 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 34' ' ' ARG . 53.9 Cg_endo -69.78 3.94 2.49 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.73 2.287 . . . . 0.0 112.328 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.87 166.67 17.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -99.11 162.67 12.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.898 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 15.9 tp10 -105.86 -41.74 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.4 mmt -66.92 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.3 p -93.36 18.53 9.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 30' ' ' CYS . 43.1 m 33.64 34.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 30' ' ' CYS . 45.8 ttt85 -79.57 116.26 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.49 142.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.65 HH12 HG23 ' A' ' 40' ' ' VAL . 17.0 ttp180 -64.6 141.53 98.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.582 0.706 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.7 133.4 25.57 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.697 2.265 . . . . 0.0 112.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 37' ' ' ALA . 7.9 tt0 -53.87 -50.39 66.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . -33.73 -63.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 11' ' ' TRP . 56.0 t80 -58.71 116.18 3.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -105.35 142.16 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG23 HH12 ' A' ' 34' ' ' ARG . 79.0 t -62.36 126.05 87.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.601 0.715 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 133.32 25.42 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 173.72 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.06 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.6 p 46.16 41.42 8.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.565 ' OH ' HG11 ' A' ' 9' ' ' VAL . 25.3 t80 -125.13 41.28 3.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' TYR . 13.7 tt0 -36.96 120.3 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.601 0.715 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 174.52 9.42 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -55.45 -43.32 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.94 81.31 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -178.85 2.53 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.706 2.27 . . . . 0.0 112.378 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 t -91.56 149.5 21.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -104.28 150.6 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.146 -0.808 . . . . 0.0 112.515 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -47.9 -53.96 14.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.841 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m -83.9 -57.86 3.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.42 -117.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 t -128.69 155.02 45.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.383 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.8 t -109.11 150.73 27.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.88 167.36 35.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -179.33 2.83 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.676 2.251 . . . . 0.0 112.351 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG11 ' OH ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -74.67 178.94 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.55 154.59 21.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.512 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 62.7 p-90 -95.9 118.87 33.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.665 0.269 . . . . 0.0 110.954 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' CA ' ' A' ' 17' ' ' THR . 3.3 tt0 -67.88 115.4 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.4 t -41.78 127.97 2.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' CD ' ' HD3' ' A' ' 35' ' ' PRO . 53.8 Cg_endo -69.81 6.07 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.81 -49.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 19.6 p -110.07 5.83 22.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.89 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' CA ' ' HG2' ' A' ' 12' ' ' GLN . 75.4 p 46.36 39.7 6.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.197 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' ILE . 64.7 t80 -91.16 87.97 6.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' PHE . 26.8 mm -33.8 97.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' PHE . 52.3 m-80 -96.38 132.63 41.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -45.33 149.07 1.02 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.548 0.69 . . . . 0.0 110.863 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 44' ' ' TYR . 54.3 Cg_endo -69.72 2.78 3.21 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.3 p -104.84 -22.64 13.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -99.13 104.56 26.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.624 0.726 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 4.08 2.39 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.48 19.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -100.14 163.33 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.745 0.307 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 7.1 tp10 -105.52 -38.61 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mmt -70.59 -76.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 32' ' ' ARG . 30.4 p -92.67 16.78 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 30' ' ' CYS . 27.3 m 36.8 30.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.49 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 23.5 ttt180 -75.86 117.79 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.15 148.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 37.1 ttp180 -70.92 136.87 85.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' CD ' ' A' ' 14' ' ' PRO . 54.0 Cg_endo -69.82 132.45 23.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 0.0 112.351 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -57.69 -41.92 82.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -38.73 -62.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 11' ' ' TRP . 59.1 t80 -41.59 155.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.29 140.8 51.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.91 123.95 15.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 0.0 111.181 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 136.55 33.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.23 -66.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -84.78 131.78 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 50.8 t80 -144.38 128.7 17.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -125.03 115.16 26.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.76 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.733 2.288 . . . . 0.0 112.322 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.1 m 66.73 45.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -162.96 5.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 0.61 5.43 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.737 2.291 . . . . 0.0 112.309 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 t -55.89 -45.69 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.861 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -116.21 91.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.132 -0.815 . . . . 0.0 112.48 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.2 p 44.38 42.34 5.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.854 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -73.22 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.2 66.91 1.73 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -39.19 -45.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.6 t -99.78 95.91 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -43.86 159.49 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -179.83 3.22 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.55 -176.76 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.34 153.18 5.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.527 ' CD2' ' HG3' ' A' ' 34' ' ' ARG . 60.5 p-90 -95.4 119.0 33.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.307 . . . . 0.0 110.882 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -64.79 115.49 5.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' THR . 2.5 t -43.73 127.27 4.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 5.76 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.372 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.53 -47.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 18' ' ' PHE . 16.7 p -111.45 2.91 17.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 82.6 p 48.78 38.74 12.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 85.8 t80 -90.85 87.26 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' PHE . 21.3 mm -33.45 94.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' PHE . 55.4 m-80 -94.38 133.29 38.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -44.36 148.93 0.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 0.0 110.904 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.75 3.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 0.0 112.37 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.0 p -104.64 -24.01 13.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 21.8 ttt85 -94.44 105.51 18.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' ARG . 53.7 Cg_endo -69.79 3.74 2.61 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.712 2.275 . . . . 0.0 112.351 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -131.27 173.43 20.38 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -100.43 162.69 12.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 1.7 tm-20 -105.17 -39.6 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.9 mmt -69.69 -77.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' ARG . 32.1 p -93.57 17.95 10.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' CYS . 35.1 t 33.61 34.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' N ' ' HB3' ' A' ' 27' ' ' CYS . 52.5 ttm-85 -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' ARG . . . -36.22 150.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HG3' ' CD2' ' A' ' 11' ' ' TRP . 45.3 ttp180 -74.73 140.25 74.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 34' ' ' ARG . 54.0 Cg_endo -69.78 137.8 36.27 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.91 -43.8 98.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.63 -49.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -62.07 149.8 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.902 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -124.68 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.8 t -101.51 130.86 23.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 162.03 43.65 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.369 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -49.96 -178.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 42' ' ' ALA . 37.5 m -33.27 98.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.74 123.17 43.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.52 118.74 74.09 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' SER . 53.6 Cg_endo -69.75 -173.33 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.662 2.241 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' PRO . 20.5 p -34.95 -53.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.63 89.38 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.55 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.71 2.274 . . . . 0.0 112.343 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -113.19 -52.32 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.6 t -87.29 83.21 7.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.461 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_